| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72511-479-02 | 72511-479 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20241108 | N/A | BLA | BLA761024 | Amgen USA Inc. | ADALIMUMAB | 40 mg/.4mL | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
| 72511-481-02 | 72511-481 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20241015 | N/A | BLA | BLA761024 | Amgen USA Inc. | ADALIMUMAB | 80 mg/.8mL | 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
| 72511-482-01 | 72511-482 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230814 | N/A | BLA | BLA761024 | Amgen USA Inc. | ADALIMUMAB | 40 mg/.4mL | 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE |
| 72511-482-02 | 72511-482 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230814 | N/A | BLA | BLA761024 | Amgen USA Inc. | ADALIMUMAB | 40 mg/.4mL | 2 SYRINGE in 1 CARTON (72511-482-02) / .4 mL in 1 SYRINGE |
| 72511-400-02 | 72511-400 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230131 | N/A | BLA | BLA761024 | Amgen USA Inc. | ADALIMUMAB | 40 mg/.8mL | 2 SYRINGE in 1 CARTON (72511-400-02) / .8 mL in 1 SYRINGE |
| 72511-400-01 | 72511-400 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230131 | N/A | BLA | BLA761024 | Amgen USA Inc. | ADALIMUMAB | 40 mg/.8mL | 1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE |
| 72511-399-01 | 72511-399 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20241108 | N/A | BLA | BLA761024 | Amgen USA Inc. | ADALIMUMAB | 20 mg/.2mL | 1 SYRINGE in 1 CARTON (72511-399-01) / .2 mL in 1 SYRINGE |
| 84612-399-01 | 84612-399 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20250101 | N/A | BLA | BLA761024 | Optum Health Solutions (Ireland) Limited | ADALIMUMAB | 20 mg/.2mL | 1 SYRINGE in 1 CARTON (84612-399-01) / .2 mL in 1 SYRINGE |
| 84612-481-02 | 84612-481 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20250101 | N/A | BLA | BLA761024 | Optum Health Solutions (Ireland) Limited | ADALIMUMAB | 80 mg/.8mL | 2 SYRINGE in 1 CARTON (84612-481-02) / .8 mL in 1 SYRINGE |
| 84612-482-01 | 84612-482 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20250101 | N/A | BLA | BLA761024 | Optum Health Solutions (Ireland) Limited | ADALIMUMAB | 40 mg/.4mL | 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE |
| 84612-482-02 | 84612-482 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20250101 | N/A | BLA | BLA761024 | Optum Health Solutions (Ireland) Limited | ADALIMUMAB | 40 mg/.4mL | 2 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGE |
| 84612-479-01 | 84612-479 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20250101 | N/A | BLA | BLA761024 | Optum Health Solutions (Ireland) Limited | ADALIMUMAB | 40 mg/.4mL | 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
| 55513-400-01 | 55513-400 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230131 | N/A | BLA | BLA761024 | Amgen Inc | ADALIMUMAB | 40 mg/.8mL | 1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE |
| 55513-400-02 | 55513-400 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230131 | N/A | BLA | BLA761024 | Amgen Inc | ADALIMUMAB | 40 mg/.8mL | 2 SYRINGE in 1 CARTON (55513-400-02) / .8 mL in 1 SYRINGE |
| 55513-400-91 | 55513-400 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230131 | N/A | BLA | BLA761024 | Amgen Inc | ADALIMUMAB | 40 mg/.8mL | 1 SYRINGE in 1 CARTON (55513-400-91) / .8 mL in 1 SYRINGE |
| 55513-410-01 | 55513-410 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230131 | N/A | BLA | BLA761024 | Amgen Inc | ADALIMUMAB | 40 mg/.8mL | 1 SYRINGE in 1 CARTON (55513-410-01) / .8 mL in 1 SYRINGE |
| 55513-410-02 | 55513-410 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230131 | N/A | BLA | BLA761024 | Amgen Inc | ADALIMUMAB | 40 mg/.8mL | 2 SYRINGE in 1 CARTON (55513-410-02) / .8 mL in 1 SYRINGE |
| 84612-479-02 | 84612-479 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20250101 | N/A | BLA | BLA761024 | Optum Health Solutions (Ireland) Limited | ADALIMUMAB | 40 mg/.4mL | 2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
| 84612-481-01 | 84612-481 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20250101 | N/A | BLA | BLA761024 | Optum Health Solutions (Ireland) Limited | ADALIMUMAB | 80 mg/.8mL | 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE |
| 55513-399-01 | 55513-399 | HUMAN PRESCRIPTION DRUG | AMJEVITA | adalimumab-atto | INJECTION | SUBCUTANEOUS | 20230814 | N/A | BLA | BLA761024 | Amgen Inc | ADALIMUMAB | 20 mg/.2mL | 1 SYRINGE in 1 CARTON (55513-399-01) / .2 mL in 1 SYRINGE |
符合检索条件的记录共 30 条，共 2 页，当前第 1 页 ，
可点击列名称排序
可点击列名称排序